Gender differences in TRH-stimulated TSH and prolactin in primary degenerative dementia and elderly controls

Biological Psychiatry
M W DyskenD D Krahn

Abstract

We performed thyrotropin-releasing hormone (TRH) stimulation testing in 18 nondepressed patients with primary degenerative dementia (10 M, 8F; average age +/- SD = 68 +/- 7) and 12 elderly controls (7M, 5F; average age +/- SD = 61 +/- 6). Six patients were retested approximately 2 years later. Initial Mini-Mental State Examination scores for patients ranged from 2 to 28 (average +/- SD = 18 +/- 6) and the scores for the control subjects were all equal to 30. Protirelin (500 micrograms) was injected iv and blood was sampled at 0, 15, 30, 45, 60, and 90 min for thyrotropin-stimulating hormone (TSH) and prolactin (PRL). There were no significant differences between patients and controls in baseline T4, T3 uptake, TSH, or PRL. No significant differences were found between patients and controls for either TRH-stimulated TSH or PRL at all time points. Duration of illness, severity of dementia, and severity of depressive symptoms did not correlate significantly with stimulation test results. There were, however, significantly greater responses in stimulated TSH and PRL for women compared with men in both patients and controls. Upon repeat testing (n = 6), TRH-stimulated TSH and PRL were not significantly different from the initial res...Continue Reading

References

Dec 1, 1985·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·R A Ferriani, M F Silva de Sá
Oct 1, 1988·Neuroendocrinology·M FranceschiN Canal
May 1, 1986·Biological Psychiatry·C A PeabodyJ R Tinklenberg
Aug 1, 1986·Biological Psychiatry·P A NewhouseR M Cohen
Aug 1, 1987·Acta Psychiatrica Scandinavica·D R ThomasR John
Jan 1, 1988·Psychoneuroendocrinology·T H LampeM A Raskind
Oct 1, 1988·Journal of Clinical and Experimental Neuropsychology·C L GradyS I Rapoport
Jan 1, 1988·Neurobiology of Aging·W H Riege, E J Metter
Dec 1, 1985·Psychiatry Research·T SunderlandR M Cohen
Jul 3, 1971·Lancet·B J OrmstonR Hall
Jun 1, 1973·The Journal of Clinical Endocrinology and Metabolism·L S JacobsW H Daughaday
Feb 1, 1972·The Journal of Clinical Endocrinology and Metabolism·P J Snyder, R D Utiger
Jun 1, 1972·The Journal of Clinical Endocrinology and Metabolism·P J Snyder, R D Utiger

❮ Previous
Next ❯

Citations

Jul 30, 2015·Clinical Endocrinology·Marco RussoDamiano Gullo
Jan 23, 1998·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·L GaspariniS Govoni

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.